Intracameral sustained release therapeutic agent implants

Details for Australian Patent Application No. 2011207281 (hide)

Owner Allergan, Inc.

Inventors Robinson, Michael R.; Burke, James; Schiffman, Rhett

Agent Davies Collison Cave

Pub. Number AU-A-2011207281

PCT Pub. Number WO2011/091205

Priority 61/297,660 22.01.10 US

Filing date 21 January 2011

Wipo publication date 28 July 2011

International Classifications

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 31/5575

A61K 47/34 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/091205 Priority application(s): WO2011/091205

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011207289-Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof

2011207280-5-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye